Post job

Lilly Del Caribe Inc main competitors are Sigma-Aldrich, Lannett, and Mylan.

Competitor Summary. See how Lilly Del Caribe Inc compares to its main competitors:

  • Mylan has the most employees (35,000).
  • Employees at Sigma-Aldrich earn more than most of the competitors, with an average yearly salary of $69,774.
Work at Lilly Del Caribe Inc?
Share your experience

Lilly Del Caribe Inc vs competitors

CompanyFounding dateZippia scoreHeadquarters# of LocationsRevenueEmployees
-
3.9
--$56.0M326
1983
4.1
Huntsville, AL1$230.0M7,500
1964
3.4
Wilmington, DE1$2.4M50
1946
4.9
Eatontown, NJ7$150.0M249
1931
3.8
Waltham, MA1$81.0M30,000
1971
4.8
Lake Forest, IL7$682.4M2,227
2007
4.2
Lexington, KY1$3.5M50
1954
4.8
Billerica, MA1$7.2B6,100
1968
4.3
Vacaville, CA1$200.0M10,000
1942
4.8
Philadelphia, PA3$340.6M1,020
-
4.2
New Albany, OH1$6.5M84
1951
4.9
Saint Louis, MO2$2.8B9,600
1993
4.9
Hayward, CA1$775.8M1,257
1987
3.6
Miami, FL1$2.2B10,100
1996
4.4
Baudette, MN1$614.4M601
Pyramid Laboratories
1988
3.6
Costa Mesa, CA1$8.5M10
1961
4.8
Canonsburg, PA2$11.5B35,000

Rate Lilly Del Caribe Inc's competitiveness in the market.

Zippia waving zebra

Lilly Del Caribe Inc salaries vs competitors

Among Lilly Del Caribe Inc competitors, employees at Sigma-Aldrich earn the most with an average yearly salary of $69,774.

Compare Lilly Del Caribe Inc salaries vs competitors

CompanyAverage salaryHourly salarySalary score
Lilly Del Caribe Inc
$52,854$25.41-
Qualitest Pharmaceuticals
$44,685$21.48-
SPI Pharma
$65,285$31.39-
West-Ward Pharmaceuticals
$59,065$28.40-
Asahi Kasei America
$57,240$27.52-
Akorn
$62,397$30.00-

Compare Lilly Del Caribe Inc job title salaries vs competitors

CompanyHighest salaryHourly salary
Lilly Del Caribe Inc
$108,593$52.21
Ani Pharmaceuticals
$111,397$53.56
Ivax Research
$111,335$53.53
Coldstream Labs
$111,328$53.52
PharmaForce Inc.
$111,190$53.46
SPI Pharma
$110,877$53.31
Pyramid Laboratories
$110,533$53.14
Qualitest Pharmaceuticals
$109,000$52.40
Mylan
$108,989$52.40
West-Ward Pharmaceuticals
$108,963$52.39
Asahi Kasei America
$108,296$52.07
Impax Laboratories
$107,370$51.62
ALZA Corporation
$106,988$51.44
EMD Millipore
$105,197$50.58
Sigma-Aldrich
$102,324$49.19
Lannett
$101,591$48.84
Akorn
$99,617$47.89

Do you work at Lilly Del Caribe Inc?

Is Lilly Del Caribe Inc able to compete effectively with similar companies?

Lilly Del Caribe Inc jobs

Lilly Del Caribe Inc demographics vs competitors

Compare gender at Lilly Del Caribe Inc vs competitors

Job titleMaleFemale
Akorn54%46%
Ani Pharmaceuticals55%45%
Lilly Del Caribe Inc55%45%
EMD Millipore57%43%
Ivax Research57%43%
Lannett72%28%

Compare race at Lilly Del Caribe Inc vs competitors

CompanyWhiteHispanic or LatinoBlack or African AmericanAsianUnknownDiversity score
35%58%2%4%1%
6.5
61%15%11%9%4%
9.4
61%6%21%9%3%
9.4
58%13%9%16%3%
9.4
62%14%6%15%3%
9.8
45%35%9%8%3%
8.1

Lilly Del Caribe Inc and similar companies CEOs

CEOBio
Douglas S. Boothe
Akorn

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Nikhil Lalwani
Ani Pharmaceuticals

Nikhil Lalwani is a Board Member at ANI PHARMACEUTICALS INC and President/CEO at ANI PHARMACEUTICALS INC. He has worked as Chief Executive Officer at Cipla USA Inc.. Nikhil studied at Georgia Tech and The Wharton School.

Timothy C. Crew
Lannett

Timothy Crew is a Chief Executive Officer at LANNETT CO INC and Board Member at LANNETT CO INC. He has worked as VP:Alliances & Business Development at Teva Pharmaceutical Indus Ltd, Captain at United States Army, and CEO:North America at cipla. Timothy works or has worked at BRISTOL MYERS SQUIBB CO. He attended Columbia Graduate School of Business and Pomona.

Richard A. Miller
Ivax Research

Heather Bresch
Mylan

Heather Manchin Bresch (Manchin; born June 27, 1969) is an American business executive. In 2012, she was named as the chief executive officer (CEO) of Netherlands-based pharmaceutical company Mylan, becoming the first woman to run a Fortune 500 pharmaceutical company. Bresch retired in 2020, upon the closing of Mylan’s combination with Upjohn. In 2015, she was listed as #22 in Fortune magazine's “Most Powerful Women” list.

Scott Thomson
SPI Pharma

Takashi Mukuno
Asahi Kasei America

Daniel Dimitri
PharmaForce Inc.

Eric Smart
Coldstream Labs

Lilly Del Caribe Inc competitors FAQs

Search for jobs